Beyond the Ligand: Winning the Isotope Wars in Radiopharma’s New Era
The field of radioligand therapy (RLT) is in the midst of a historic boom. With well over 300 therapeutic trials currently active, a new generation of cancer treatments is rapidly advancing towards the clinic. For years, the central challenge was a biological one: finding the right molecule, the perfect ligand to target cancer cells with […]